You have 9 free searches left this month | for more free features.

21-166

Showing 1 - 25 of 6,793

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)

Recruiting
  • Liver Metastases
  • Breast Cancer
  • Quiremspheres™
  • Leuven, Vlaams-Brabant, Belgium
  • +1 more
Nov 16, 2023

Effectiveness in Patients With Metabolic Syndrome (TRISTAN)

Completed
  • Hypertriglyceridemia
  • Metabolic Syndrome
  • Tricor (fenofibrate), 145 mg, film-coated tablet
  • Barnaul, Russian Federation
  • +62 more
Dec 14, 2021

Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)

Completed
  • Respiratory Syncytial Virus
  • Ad26.RSV.preF
  • +2 more
  • Geelong, Australia
  • +24 more
Nov 23, 2021

Hepatocellular Carcinoma Non-resectable Trial (Holmium-166 radioembolization)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Holmium-166 radioembolization
  • Utrecht, Netherlands
    UMC Utrecht
Nov 7, 2022

Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)

Recruiting
  • Schizophrenia
  • SEP-363856 75mg
  • +2 more
  • Little Rock, Arkansas
  • +63 more
Dec 12, 2022

Liver Cancer, Liver Metastasis Colon Cancer, Primary Liver Cancer Trial (Fractional administration device)

Not yet recruiting
  • Liver Cancer
  • +2 more
  • Fractional administration device
  • (no location specified)
Jan 13, 2022

Amyotrophic Lateral Sclerosis Trial in Charlotte (Placebo (for MN-166), MN-166, riluzole)

Completed
  • Amyotrophic Lateral Sclerosis
  • Placebo (for MN-166)
  • +2 more
  • Charlotte, North Carolina
    Carolinas Healthcare System, Dept. of Neurology
Oct 7, 2021

Delinquency, Drug Use Trial in Eugene (Treatment Foster Care (TFCO), Group Care)

Completed
  • Delinquency
  • Drug Use
  • Treatment Foster Care (TFCO)
  • Group Care
  • Eugene, Oregon
  • +1 more
Feb 23, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022

Holmium-166 Retrospective Collection of Real-World Data

Completed
  • Hepatocellular Carcinoma
  • Metastatic Cancer
  • Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres
  • Aalst, Belgium
  • +11 more
Aug 29, 2022

Pancreas Cancer Trial in Nijmegen (Intratumoral)

Recruiting
  • Pancreas Cancer
  • Intratumoral
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Centre
May 19, 2023

Pneumonia, Viral Trial in Denver, New Haven (Ibudilast, Placebo)

Active, not recruiting
  • Pneumonia, Viral
  • Denver, Colorado
  • +1 more
Aug 24, 2022

Peanut Allergy Trial in Worldwide (Viaskin Peanut 250 mcg, Viaskin Peanut 100 mcg, Placebo)

Active, not recruiting
  • Peanut Allergy
  • Viaskin Peanut 250 mcg
  • +2 more
  • Tucson, Arizona
  • +50 more
Apr 23, 2021

Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

Recruiting
  • Bladder Cancer
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 22, 2022

Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)

Not yet recruiting
  • Primary Liver Cancer
  • Non-Resectable Hepatocellular Carcinoma
  • MRI-guided radioembolization
  • (no location specified)
Nov 1, 2022

Amyotrophic Lateral Sclerosis Trial in Canada, United States (MN-166, )

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Orange, California
  • +23 more
Jan 24, 2023

Diabetic Nephropathies Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

Completed
  • Diabetic Nephropathies
  • Finerenone (BAY94-8862)
  • Placebo
  • Birmingham, Alabama
  • +146 more
Jun 30, 2021

Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)

Completed
  • Dry Eye Disease
  • CyclASol topical ocular, eye drops
  • Vehicle topical ocular, eye drops
  • Newport Beach, California
  • +8 more
Dec 21, 2022

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • La Jolla, California
  • +159 more
Jan 23, 2023

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Diabetes Trial in Al Madinah, Riyadh (Home Healthcare)

Completed
  • Diabetes Mellitus
  • Home Healthcare
  • Al Madinah, Saudi Arabia
  • +1 more
Jun 23, 2023

OCD, Anxiety Disorders, Pediatric Disorder Trial in Riverside (Exposure Therapy)

Recruiting
  • Obsessive-Compulsive Disorder
  • +13 more
  • Exposure Therapy
  • Riverside, Rhode Island
    Bradley Hospital
Aug 2, 2022

Serum Magnesium Level in Type 2 Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus
  • Magnesium
  • Sohag, Egypt
    Sohag university Hospital
Sep 22, 2023

Physical Activity, Diet Modification Trial in Bath (Diet)

Completed
  • Physical Activity
  • Diet Modification
  • Diet
  • Bath, United Kingdom
    Department for Health, University of Bath
Oct 7, 2022

Poly Cystic Ovary Syndrome Trial (Daflon, Combined oral contraceptive, Metformin)

Not yet recruiting
  • Poly Cystic Ovary Syndrome
  • (no location specified)
Oct 9, 2023